Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare
Cartesian Therapeutics Inc. Net Income 2014–2025
Cartesian Therapeutics Inc. annual/quarterly net income history and growth rate from 2014 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cartesian Therapeutics Inc. net income for the quarter ending March 31, 2026 was -39.2 M, a 121.24% increase year-over-year.
- Cartesian Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -76.9 M, a 0.96% increase year-over-year.
- Cartesian Therapeutics Inc. annual net income for 2025 was -130.3 M, a 68.30% increase from 2024.
- Cartesian Therapeutics Inc. annual net income for 2024 was -77.4 M, a 64.76% decrease from 2023.
- Cartesian Therapeutics Inc. annual net income for 2023 was -219.7 M, a 721.02% decrease from 2022.
- Cartesian Therapeutics Inc. annual net income for 2022 was 35.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cartesian Therapeutics Inc. Net Income — FAQ
Cartesian Therapeutics Inc. (RNAC) net income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Cartesian Therapeutics Inc.'s net income?
Cartesian Therapeutics Inc. (RNAC) reported net income of -$130M for fiscal 2025.
Where can I see RNAC's net income history?
The chart and table above show Cartesian Therapeutics Inc.'s net income by year and by quarter, including the growth rate.